Frontiers in Immunology · 2024 · 58 citations · 100 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyCancer ImmunotherapyGerminal Center ReactionsLymphocyte ActivationLymphoid NeoplasmsLymphoid TissueTumor-infiltrating LymphocytesAdaptive Antitumor ImmunityAntitumor Immune ActivationEctopic Germinal CentersGerminal Center PathologyImmune Cell ActivationLymphocyte SubtypesLymphoid Tissue ArchitectureTertiary Lymphoid Structures
Tertiary lymphoid structure (TLS) is an ectopic lymphocyte aggregate formed in peripheral non-lymphoid tissues, including inflamed or cancerous tissue. Tumor-associated TLS serves as a prominent center of antigen presentation and adaptive immune activation within the periphery, which has exhibited positive prognostic value in various cancers. In recent years, the concept of maturity regarding TLS has been proposed and mature TLS, characterized by well-developed germinal centers, exhibits a more potent tumor-suppressive capacity with stronger significance. Meanwhile, more and more evidence showed that TLS can be induced by therapeutic interventions during cancer treatments. Thus, the evaluation of TLS maturity and the therapeutic interventions that induce its formation are critical issues in current TLS research. In this review, we aim to provide a comprehensive summary of the existing classifications for TLS maturity and therapeutic strategies capable of inducing its formation in tumors.
100
B cells and tertiary lymphoid structures promote immunotherapy response
Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao et al. · Nature · 2020 · 2.7K citations · Full text
Tertiary lymphoid structures improve immunotherapy and survival in melanoma
Rita Cabrita, Martin Lauss, Adriana Sanna et al. · Nature · 2020 · 2.3K citations · Full text
Medicine, Immunology, Oncology +12
B cells are associated with survival and immunotherapy response in sarcoma
Florent Petitprez, Aurélien de Reyniès, Emily Z. Keung et al. · Nature · 2020 · 1.9K citations · Full text
Medicine, Immunology, Oncology +17
CD4+ follicular helper T cell infiltration predicts breast cancer survival
Chunyan Gu‐Trantien, Sherene Loi, Soizic Garaud et al. · Journal of Clinical Investigation · 2013 · 1.1K citations
Life Sciences, Immunology, Oncology +17